We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
(+1.4%)
Cap. Flow
-$1.3B
Cap. Flow
% of AUM
-5.9%
Top 10 Holdings %
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$148M |
| 2 |
Netflix
NFLX
|
+$119M |
| 3 |
Airbnb
ABNB
|
+$111M |
| 4 |
XYZ
Block Inc
XYZ
|
+$89.5M |
| 5 |
Danaher
DHR
|
+$88.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles River Laboratories
CRL
|
+$212M |
| 2 |
Alibaba
BABA
|
+$172M |
| 3 |
Zoetis
ZTS
|
+$133M |
| 4 |
TransUnion
TRU
|
+$124M |
| 5 |
Baidu
BIDU
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.88% |
| 2 | Financials | 13.4% |
| 3 | Consumer Discretionary | 12.06% |
| 4 | Technology | 11.2% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Banco Bilbao Vizcaya Argentaria
BBVA
$142B
| $88K | ﹤0.01% |
+14,214
| New | +$84.1K |
|
2527
Carnival Corporation Ltd
CCL
$38.1B
| $88K | ﹤0.01% |
3,341
-2,416,676
| -100% | -$67.7M |
|
2528
BioCardia
BCDA
$11.5M
| $86K | ﹤0.01% |
1,445
-1,219
| -46% | -$74K |
|
2529
PUT
Qualcomm
QCOM
$164B
| $86K | ﹤0.01% |
600
-16,700
| -97% | -$2.26M |
|
|
CNCE
2530
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $86K | ﹤0.01% |
20,455
-32,226
| -61% | -$136K |
|
2531
Intel
INTC
$413B
| $85K | ﹤0.01% |
1,517
-1,755,653
| -100% | -$103M |
|
|
KRKR
2532
36Kr Holdings
KRKR
$5.41M
| $84K | ﹤0.01% |
1,684
-18,664
| -92% | -$1.02M |
|
|
TOUR
2533
Tuniu
TOUR
$56.2M
| $84K | ﹤0.01% |
3,548
-41,137
| -92% | -$1.12M |
|
2534
PUT
Berkshire Hathaway Class B
BRK.B
$1.1T
| $83K | ﹤0.01% |
+300
| New | +$83.8K |
|
2535
Tantech Holdings
TANH
$5.96M
| $81K | ﹤0.01% |
7
-29
| -81% | -$344K |
|
|
PVLA
2536
Palvella Therapeutics
PVLA
$2.05B
| $78K | ﹤0.01% |
+255
| New | +$55.9K |
|
|
CLPR
2537
Clipper Realty
CLPR
$46.4M
| $74K | ﹤0.01% |
+10,024
| New | +$81.3K |
|
2538
Flotek Industries
FTK
$789M
| $73K | ﹤0.01% |
7,022
-1,470
| -17% | -$15.8K |
|
2539
PUT
Charter Communications
CHTR
$17.3B
| $72K | ﹤0.01% |
+100
| New | +$67.3K |
|
|
RESN
2540
DELISTED
Resonant Inc.
RESN
| $68K | ﹤0.01% |
+21,126
| New | +$72.5K |
|
2541
Orion Energy Systems
OESX
$38.9M
| $67K | ﹤0.01% |
+1,163
| New | +$70.6K |
|
|
LJPC
2542
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $67K | ﹤0.01% |
+15,572
| New | +$66.7K |
|
|
MCF
2543
DELISTED
Contango Oil & Gas Co.
MCF
| $66K | ﹤0.01% |
+15,332
| New | +$64.3K |
|
2544
PUT
Lam Research
LRCX
$316B
| $65K | ﹤0.01% |
+1,000
| New | +$63.1K |
|
2545
AmpliTech
AMPG
$117M
| $64K | ﹤0.01% |
+13,835
| New | +$79.6K |
|
2546
PUT
American International
AIG
$42.5B
| $62K | ﹤0.01% |
+1,300
| New | +$64.3K |
|
2547
RPC Inc
RES
$1.13B
| $62K | ﹤0.01% |
+12,494
| New | +$67.3K |
|
2548
PUT
Ford
F
$60.9B
| $59K | ﹤0.01% |
+4,000
| New | +$53.2K |
|
2549
PUT
Southwest Airlines
LUV
$21.7B
| $58K | ﹤0.01% |
1,100
-17,700
| -94% | -$1.06M |
|
|
CD
2550
Chaince Digital Holdings
CD
$226M
| $57K | ﹤0.01% |
+9,963
| New | +$67.7K |
|
Similar funds
Marshall Wace's Q2 2021 Portfolio in Review
As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.
- Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
- Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
- Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
- Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
- Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
- Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
- Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.
Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.